{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:44:26Z","timestamp":1785897866636,"version":"3.56.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82504141"],"award-info":[{"award-number":["No. 82504141"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 32130036"],"award-info":[{"award-number":["No. 32130036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the National Clinical Key Specialty Construction Project","award":["10000015Z155080000004"],"award-info":[{"award-number":["10000015Z155080000004"]}]},{"name":"Guizhou Provincial Science and Technology Projects","award":["No. Qiankeherencai XKBF [2025]025"],"award-info":[{"award-number":["No. Qiankeherencai XKBF [2025]025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04625-6","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:45:12Z","timestamp":1780321512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Supramolecular coordination nanoplatform amplifies oxidative stress to overcome ferroptosis resistance in gallbladder cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuhao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenguang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meidong","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"issue":"2","key":"4625_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5114\/ceh.2019.85166","volume":"5","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Thandra KC, Barsouk A. Epidemiology of gallbladder cancer. Clin Exp Hepatol. 2019;5(2):93\u2013102. https:\/\/doi.org\/10.5114\/ceh.2019.85166.","journal-title":"Clin Exp Hepatol"},{"issue":"3","key":"4625_CR2","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ccell.2025.02.011","volume":"43","author":"M Yang","year":"2025","unstructured":"Yang M, Zhao Y, Li C, Weng X, Li Z, Guo W, Jia W, Feng F, Hu J, Sun H, Wang B, Li H, Li M, Wang T, Zhang W, Jiang X, Zhang Z, Liu F, Hu H, Wu X, et al. Multimodal integration of liquid biopsy and radiology for the noninvasive diagnosis of gallbladder cancer and benign disorders. Cancer Cell. 2025;43(3):398\u2013e412394. https:\/\/doi.org\/10.1016\/j.ccell.2025.02.011.","journal-title":"Cancer Cell"},{"issue":"5","key":"4625_CR3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/cm9.0000000000002759","volume":"137","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Yang M, Feng J, Wang X, Liu Y. Advances in immunotherapy for biliary tract cancers. Chin Med J (Engl). 2024;137(5):524\u201332. https:\/\/doi.org\/10.1097\/cm9.0000000000002759.","journal-title":"Chin Med J (Engl)"},{"key":"4625_CR4","doi-asserted-by":"publisher","unstructured":"Vogel A, Bridgewater J, Edeline J, Kelley RK, Klumpen HJ, Malka D, Primrose JN, Rimassa L, Stenzinger A, Valle JW, Ducreux M, clinicalguidelines@esmo.org EG. C. E. a. Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(2):127\u201340. https:\/\/doi.org\/10.1016\/j.annonc.2022.10.506.","DOI":"10.1016\/j.annonc.2022.10.506"},{"key":"4625_CR5","doi-asserted-by":"publisher","first-page":"1183619","DOI":"10.3389\/fphar.2023.1183619","volume":"14","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Yuan K, Yang Y, Ji Z, Zhou D, Ouyang J, Wang Z, Wang F, Liu C, Li Q, Zhang Q, Li Q, Shan X, Zhou J. Gallbladder cancer: current and future treatment options. Front Pharmacol. 2023;14:1183619. https:\/\/doi.org\/10.3389\/fphar.2023.1183619.","journal-title":"Front Pharmacol"},{"issue":"5","key":"4625_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","volume":"20","author":"JN Primrose","year":"2019","unstructured":"Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, Anthony A, Corrie P, Falk S, Finch-Jones M, Wasan H, Ross P, Wall L, Wadsley J, Evans JTR, Stocken D, Praseedom R, Ma YT, Davidson B, Neoptolemos JP, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20(5):663\u201373. https:\/\/doi.org\/10.1016\/S1470-2045(18)30915-X.","journal-title":"Lancet Oncol"},{"issue":"4","key":"4625_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.21037\/cco.2019.08.12","volume":"8","author":"V Verma","year":"2019","unstructured":"Verma V, Crane CH. Contemporary perspectives on the use of radiation therapy for locally advanced gallbladder cancer. Chin Clin Oncol. 2019;8(4):41. https:\/\/doi.org\/10.21037\/cco.2019.08.12.","journal-title":"Chin Clin Oncol"},{"key":"4625_CR8","doi-asserted-by":"publisher","unstructured":"Hu Z, Tan H, Ye Y, Xu W, Gao J, Liu L, Zhang L, Jiang J, Tian H, Peng F, Tu Y. NIR-Actuated Ferroptosis Nanomotor for Enhanced Tumor Penetration and Therapy. Adv Mater. 2024;36(49). https:\/\/doi.org\/10.1002\/adma.202412227.","DOI":"10.1002\/adma.202412227"},{"issue":"14","key":"4625_CR9","doi-asserted-by":"publisher","first-page":"14233","DOI":"10.1021\/acsnano.5c00730","volume":"19","author":"M Zhang","year":"2025","unstructured":"Zhang M, Zheng H, Zhu X, Liu S, Jin H, Chen Y, Wan L, Zhang S, Zhang H. Synchronously Evoking Disulfidptosis and Ferroptosis via Systematical Glucose Deprivation Targeting SLC7A11\/GSH\/GPX4 Antioxidant Axis. ACS Nano. 2025;19(14):14233\u201348. https:\/\/doi.org\/10.1021\/acsnano.5c00730.","journal-title":"ACS Nano"},{"issue":"17","key":"4625_CR10","doi-asserted-by":"publisher","first-page":"e2303896","DOI":"10.1002\/adhm.202303896","volume":"13","author":"C Zhou","year":"2024","unstructured":"Zhou C, Zhao Y, Yang M, Yin W, Li Y, Xiao Y, Liu Y, Lang M. Diselenide-Containing Polymer Based on New Antitumor Mechanism as Efficient GSH Depletion Agent for Ferroptosis Therapy. Adv Healthc Mater. 2024;13(17):e2303896. https:\/\/doi.org\/10.1002\/adhm.202303896.","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"4625_CR11","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1186\/s12951-025-03902-0","volume":"23","author":"J Wang","year":"2025","unstructured":"Wang J, Zhao M, Zhang J, Zhang X, Zhu H, Wang C, Zhang S. Protective effects of biomimetic Cu-Zn-MOF against DOX-Induced cardiotoxicity through inhibiting oxidative stress and ferroptosis. J Nanobiotechnol. 2025;23(1):768. https:\/\/doi.org\/10.1186\/s12951-025-03902-0.","journal-title":"J Nanobiotechnol"},{"key":"4625_CR12","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.drup.2022.100916","volume":"66","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wu X, Ren Z, Li Y, Zou W, Chen J, Wang H. Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat. 2023;66:100916. https:\/\/doi.org\/10.1016\/j.drup.2022.100916.","journal-title":"Drug Resist Updat"},{"key":"4625_CR13","doi-asserted-by":"publisher","unstructured":"Xu W, Yang Y, Liu L, Hu B, Tang Y, Ding H, Zhang L, Yang P, Wang C. Dual-Release Free Iron and Breakdown of Ferroptosis Defenses to Achieve Ferroptosis Cascade Storms for Potent Antitumor Therapy. Adv Funct Mater. 2025;35(24). https:\/\/doi.org\/10.1002\/adfm.202420540.","DOI":"10.1002\/adfm.202420540"},{"issue":"1","key":"4625_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12951-025-03206-3","volume":"23","author":"Z Lin","year":"2025","unstructured":"Lin Z, Li Y, Wu Z, Liu Q, Li X, Luo W. Eriodictyol-cisplatin coated nanomedicine synergistically promote osteosarcoma cells ferroptosis and chemosensitivity. J Nanobiotechnol. 2025;23(1):109. https:\/\/doi.org\/10.1186\/s12951-025-03206-3.","journal-title":"J Nanobiotechnol"},{"issue":"18","key":"4625_CR15","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1097\/CM9.0000000000002675","volume":"136","author":"Z Wang","year":"2023","unstructured":"Wang Z, Li W, Wang X, Zhu Q, Liu L, Qiu S, Zou L, Liu K, Li G, Miao H, Yang Y, Jiang C, Liu Y, Shao R, Wang X, Liu Y. Isoliquiritigenin induces HMOX1 and GPX4-mediated ferroptosis in gallbladder cancer cells. Chin Med J (Engl). 2023;136(18):2210\u201320. https:\/\/doi.org\/10.1097\/CM9.0000000000002675.","journal-title":"Chin Med J (Engl)"},{"issue":"8","key":"4625_CR16","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1172\/jci99032","volume":"128","author":"B Hassannia","year":"2018","unstructured":"Hassannia B, Wiernicki B, Ingold I, Qu F, Van Herck S, Tyurina YY, Bay\u0131r H, Abhari BA, Angeli JPF, Choi SM, Meul E, Heyninck K, Declerck K, Chirumamilla CS, Lahtela-Kakkonen M, Van Camp G, Krysko DV, Ekert PG, Fulda S, De Geest BG, et al. Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma. J Clin Invest. 2018;128(8):3341\u201355. https:\/\/doi.org\/10.1172\/jci99032.","journal-title":"J Clin Invest"},{"issue":"7","key":"4625_CR17","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang X, Wang H, Han D, Xie E, Yang X, Wei J, Gu S, Gao F, Zhu N, Yin X, Cheng Q, Zhang P, Dai W, Chen J, Yang F, Yang HT, Linkermann A, Gu W, Min J, Wang F. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci U S A. 2019;116(7):2672\u201380. https:\/\/doi.org\/10.1073\/pnas.1821022116.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4625_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.canlet.2017.12.025","volume":"416","author":"LC Chang","year":"2018","unstructured":"Chang LC, Chiang SK, Chen SE, Yu YL, Chou RH, Chang WC. Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis. Cancer Lett. 2018;416:124\u201337. https:\/\/doi.org\/10.1016\/j.canlet.2017.12.025.","journal-title":"Cancer Lett"},{"issue":"3","key":"4625_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ejps.2013.04.020","volume":"49","author":"XY Zhang","year":"2013","unstructured":"Zhang XY, Qiao H, Ni JM, Shi YB, Qiang Y. Preparation of isoliquiritigenin-loaded nanostructured lipid carrier and the in vivo evaluation in tumor-bearing mice. Eur J Pharm Sci. 2013;49(3):411\u201322. https:\/\/doi.org\/10.1016\/j.ejps.2013.04.020.","journal-title":"Eur J Pharm Sci"},{"key":"4625_CR20","doi-asserted-by":"publisher","first-page":"125727","DOI":"10.1016\/j.chemosphere.2019.125727","volume":"246","author":"Z Song","year":"2020","unstructured":"Song Z, Zhang Y, Zhang H, Rajendran RS, Wang R, Hsiao CD, Li J, Xia Q, Liu K. Isoliquiritigenin triggers developmental toxicity and oxidative stress-mediated apoptosis in zebrafish embryos\/larvae via Nrf2-HO1\/JNK-ERK\/mitochondrion pathway. Chemosphere. 2020;246:125727. https:\/\/doi.org\/10.1016\/j.chemosphere.2019.125727.","journal-title":"Chemosphere"},{"issue":"1","key":"4625_CR21","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1080\/21691401.2020.1825092","volume":"48","author":"G Wang","year":"2020","unstructured":"Wang G, Yu Y, Wang YZ, Yin PH, Xu K, Zhang H. The effects and mechanisms of isoliquiritigenin loaded nanoliposomes regulated AMPK\/mTOR mediated glycolysis in colorectal cancer. Artif Cells Nanomed Biotechnol. 2020;48(1):1231\u201349. https:\/\/doi.org\/10.1080\/21691401.2020.1825092.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"1","key":"4625_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","volume":"8","author":"D Fan","year":"2023","unstructured":"Fan D, Cao Y, Cao M, Wang Y, Cao Y, Gong T. Nanomedicine in cancer therapy. Signal Transduct Target Ther. 2023;8(1):293. https:\/\/doi.org\/10.1038\/s41392-023-01536-y.","journal-title":"Signal Transduct Target Ther"},{"issue":"48","key":"4625_CR23","doi-asserted-by":"publisher","first-page":"e2104223","DOI":"10.1002\/adma.202104223","volume":"33","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Fan S, Feng L, Huang X, Chen X. Manipulating Intratumoral Fenton Chemistry for Enhanced Chemodynamic and Chemodynamic-Synergized Multimodal Therapy. Adv Mater. 2021;33(48):e2104223. https:\/\/doi.org\/10.1002\/adma.202104223.","journal-title":"Adv Mater"},{"issue":"4","key":"4625_CR24","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1021\/cr5004198","volume":"115","author":"SS Lucky","year":"2015","unstructured":"Lucky SS, Soo KC, Zhang Y. Nanoparticles in photodynamic therapy. Chem Rev. 2015;115(4):1990\u20132042. https:\/\/doi.org\/10.1021\/cr5004198.","journal-title":"Chem Rev"},{"issue":"4","key":"4625_CR25","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1073\/pnas.88.4.1580","volume":"88","author":"R Bachor","year":"1991","unstructured":"Bachor R, Shea CR, Gillies R, Hasan T. Photosensitized destruction of human bladder carcinoma cells treated with chlorin e6-conjugated microspheres. Proc Natl Acad Sci U S A. 1991;88(4):1580\u20134. https:\/\/doi.org\/10.1073\/pnas.88.4.1580.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"4625_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jncc.2022.10.001","volume":"2","author":"E Wang","year":"2022","unstructured":"Wang E, Xiang K, Zhang Y, Wang XF. Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models. J Natl Cancer Cent. 2022;2(4):263\u201376. https:\/\/doi.org\/10.1016\/j.jncc.2022.10.001.","journal-title":"J Natl Cancer Cent"},{"issue":"1","key":"4625_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12951-026-04056-3","volume":"24","author":"M Luo","year":"2026","unstructured":"Luo M, Zhao FK, Ouyang CH, Wang YM, Luo Y, Bian J. Recent advances in nanomaterial-based precision medicine for orthotopic tumor therapy. J Nanobiotechnol. 2026;24(1):168. https:\/\/doi.org\/10.1186\/s12951-026-04056-3.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"4625_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41698-021-00168-1","volume":"5","author":"GE Wensink","year":"2021","unstructured":"Wensink GE, Elias SG, Mullenders J, Koopman M, Boj SF, Kranenburg OW, Roodhart JM. L. Patient-derived organoids as a predictive biomarker for treatment response in cancer patients. NPJ Precis Oncol. 2021;5(1):30. https:\/\/doi.org\/10.1038\/s41698-021-00168-1.","journal-title":"NPJ Precis Oncol"},{"key":"4625_CR29","doi-asserted-by":"publisher","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, Brown LM, Girotti AW, Cornish VW, Schreiber SL, Stockwell BR. Regulation of ferroptotic cancer cell death by GPX4. Cell 2014, 156 (1\u20132), 317\u2013331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010","DOI":"10.1016\/j.cell.2013.12.010"},{"issue":"5","key":"4625_CR30","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd;, Stockwell BR. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"issue":"10","key":"4625_CR31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nrm3873","volume":"15","author":"ER Shamir","year":"2014","unstructured":"Shamir ER, Ewald AJ. Three-dimensional organotypic culture: experimental models of mammalian biology and disease. Nat Rev Mol Cell Biol. 2014;15(10):647\u201364. https:\/\/doi.org\/10.1038\/nrm3873.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"4625_CR32","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jhep.2021.06.023","volume":"75","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zuo C, Liu L, Hu Y, Yang B, Qiu S, Li Y, Cao D, Ju Z, Ge J, Wang Q, Wang T, Bai L, Yang Y, Li G, Shao Z, Gao Y, Li Y, Bian R, Miao H, et al. Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer. J Hepatol. 2021;75(5):1128\u201341. https:\/\/doi.org\/10.1016\/j.jhep.2021.06.023.","journal-title":"J Hepatol"},{"issue":"1","key":"4625_CR33","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12967-020-02407-8","volume":"18","author":"M Jian","year":"2020","unstructured":"Jian M, Ren L, He G, Lin Q, Tang W, Chen Y, Chen J, Liu T, Ji M, Wei Y, Chang W, Xu J. A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases. J Transl Med. 2020;18(1):234. https:\/\/doi.org\/10.1186\/s12967-020-02407-8.","journal-title":"J Transl Med"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04625-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04625-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04625-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:46:47Z","timestamp":1785894407000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04625-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4625"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04625-6","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethical Committee of Renji Hospital, Shanghai Jiaotong University School of Medicine (KY2024-003) and conducted in accordance with the Declaration of Helsinki. All animal experiments involving the transplantation of cell lines and organoids were approved by the Ethical Committee of Renji Hospital, Shanghai Jiaotong University School of Medicine (RJ2024-056).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the manuscript, and agree to submit for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"720"}}